UNSPSC 51141598: Zoniclezole hydrochloride

This classification denotes an anticonvulsant agent with the molecular formula C12H10ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0VM256HNOM, chemically known as 1,2-benzisoxazole, 5-chloro-3-(1-(1h-imidazol-1-yl)ethyl)- but more generally known as zoniclezole hydrochloride, which bears US NIH Compound Identifier 60745. Most nations, for tariff and trade purposes, schedule zoniclezole hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, ZONICLEZOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Zoniclezole hydrochloride bears US NLM identifiers UMLS ID C0959127 and NCI Concept Code C82236. SMILES: CC(C1C2CC(CCC2ON1)CL)N3CCNC3.CL.

UNSPSC 51141598 Zoniclezole hydrochloride is a Commodity code with sparse recent state and local procurement activity. The three recent opportunities in the source are not aligned with this specific pharmaceutical ingredient — they cover naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS), and generic multi-source pharmaceuticals through cooperative purchasing (Minnesota). None of these solicitations directly procure zoniclezole hydrochloride or identify it as a line item, suggesting the code sees little active current demand from state and local buying offices or reflects a tagging mismatch between the code's nominal scope and the work actually being solicited.

State and local procurement activity tagged to this code does not support a reliable characterization of regular issuing bodies, geographic concentration, or ongoing business development opportunity. No award values, repeat buyers, or forward-looking demand signals are present in the available recent opportunities.